To determine whether enhanced RN glutamatergic neuronal activity would decrease anxiety levels and CCL5 production after restraint stress exposure, a recombinant hM3D(Gq) adeno-associated virus (AAV) was used; as a control, an AAV with fluorescent protein was applied (Fig. 5j). The gene discussed is CCL5; the disease is Anxiety.